Solosec (Secnidazole) Shortage: What Providers and Prescribers Need to Know in 2026

Solosec (secnidazole) is an effective, convenient, single-dose treatment for bacterial vaginosis and trichomoniasis. But in clinical practice in 2026, getting patients access to it has become increasingly complicated. This guide is designed for OB/GYNs, PCPs, NPs, and PAs who prescribe Solosec and need practical strategies to support patients when access barriers arise.

The Current Clinical Access Landscape

As of 2026, Solosec is not on the FDA's Drug Shortage Database. However, providers nationwide are reporting that patients consistently struggle to find it in stock — and when they do find it, they often face sticker shock. Retail prices range from $290 to $550 per single 2-gram packet without insurance. Even with insurance, step therapy programs at major payers like UnitedHealthcare require patients to first try and fail alternatives like metronidazole or clindamycin before coverage is approved.

The root cause is structural: Solosec is manufactured exclusively by Lupin Pharmaceuticals, and no generic has been approved by the FDA. This single-source supply model means even minor disruptions in manufacturing or distribution can create localized stockouts at pharmacies.

Why Patients Struggle: A Summary of Barriers

Pharmacy stocking: Low-volume, high-cost drug; many pharmacies keep minimal inventory

Prior authorization: Many commercial payers require PA before covering Solosec

Step therapy: UnitedHealthcare and others require documented failure of metronidazole or clindamycin before Solosec coverage is authorized

Cost: Without PA approval or copay card use, many patients face retail prices of $290–$550 for a single dose

Medicare/Medicaid: The manufacturer copay card is not valid for government payers; these patients face full retail cost if their plan doesn't cover Solosec

Evidence-Based Alternatives When Solosec Is Unavailable

The following alternatives are clinically well-supported by CDC guidelines:

For Bacterial Vaginosis (BV):

Metronidazole 500 mg PO BID × 7 days — first-line per CDC guidelines; generic, $4–$15

Metronidazole 0.75% vaginal gel 5 g QD × 5 days — preferred for minimizing systemic effects

Clindamycin 300 mg PO BID × 7 days — preferred for nitroimidazole-intolerant patients

Clindamycin 2% vaginal cream QHS × 7 days — oil-based; counseling patients on condom interaction is important

Tinidazole 2 g PO QD × 2 days — shorter course, fewer GI side effects than metronidazole

For Trichomoniasis:

Metronidazole 500 mg PO BID × 7 days — CDC-recommended for women

Tinidazole 2 g PO single dose — closest equivalent to Solosec's convenience; preferred for resistant trich

Note: Partner treatment is required for trichomoniasis regardless of which agent is chosen.

Clinical Workflow Recommendations

Verify stock before prescribing: Use medfinder at medfinder.com/providers to check real-time pharmacy inventory in your patient's area before issuing the prescription.

Write conditional backup prescriptions: Consider issuing a backup: 'If Solosec unavailable, fill Metronidazole 500 mg #28, 1 PO BID × 7 days.' Check your state's conditional prescribing regulations.

Initiate prior auth during the visit: If you know the patient's insurer requires PA, document clinical rationale during the encounter: history of non-adherence with multi-day regimens, previous metronidazole failure, or treatment preference.

Counsel on the savings card: The manufacturer copay card (solosec.com) reduces cost to $25 for commercially insured patients or $75 for cash-pay. Not valid with Medicare or Medicaid.

Document step therapy completion: If a patient has already tried metronidazole or clindamycin, document this in the chart to support PA approval for Solosec.

39,448+ patients found their medications in stock

39K+

Find Secnidazole In Stock Today →

Patient Communication Tips

Set expectations upfront: let patients know that Solosec may require some effort to locate and that insurance may require prior authorization. Giving them a clear fallback plan — and directing them to medfinder if needed — prevents follow-up calls and delays in treatment. For detailed patient-facing resources, refer patients to medfinder.com.

To streamline your prescribing workflow and help your patients find Solosec faster, visit medfinder for providers.